#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA811117	B	The cGMP produced by compound was expressed as a ratio between the percentage of the DEA/NO response for the compound		1		protein complex format	Scientific Literature
2.	ALA811118	B	IGC activation was determined in the presence of [alpha-32P]GTP at a concentration of 82 uM		1		protein complex format	Scientific Literature
3.	ALA811119	B	sGC activation was determined in the presence of [alpha-32P]GTP at a concentration of 82 uM		9		protein complex format	Scientific Literature
4.	ALA869997	F	Ratio of activation of sGC by compound over that of control, in presence of carbon monooxide (basal activity 33+/-3 nmol/min/mg in absence of CO)		5		assay format	Scientific Literature
5.	ALA867095	F	Ratio of activation of sGC by compound over that of control, in absence of carbon monooxide (basal activity 33+/-3 nmol/min/mg)		5		assay format	Scientific Literature
6.	ALA867097	F	Effect on YC-1 mediated activation of sGC in presence of carbon monoxide		1		assay format	Scientific Literature
7.	ALA865676	F	Effect on cGMP production in porcine iris-ciliary body at 10 uM	Sus scrofa	6		assay format	Scientific Literature
8.	ALA865677	F	Effect on cGMP production in porcine iris-ciliary body at 100 uM	Sus scrofa	6		assay format	Scientific Literature
9.	ALA869051	B	Inhibition of rat lung sGC	Rattus norvegicus	6		protein complex format	Scientific Literature
10.	ALA862867	B	Inhibition of stimulated guanylate cyclase at 1 uM	Homo sapiens	1		protein complex format	Scientific Literature
11.	ALA1918701	B	Activation of human soluble guanylate cyclase assessed as production of cGMP in presence of nitric oxide donor, SIN-1 by LC-MS enzyme assay	Homo sapiens	16		protein complex format	Scientific Literature
12.	ALA1918702	B	Activation of human soluble guanylate cyclase assessed as production of cGMP in presence of nitric oxide donor, SIN-1 by FP assay	Homo sapiens	10		protein complex format	Scientific Literature
13.	ALA3881285	B	Activation of sGC (unknown origin) assessed as cGMP formation using GTP as substrate by Catch-point cGMP assay relative to DMSO	Homo sapiens	24		protein complex format	Patent Bioactivity Data
14.	ALA3223739	B	Activation of soluble guanylate cyclase (unknown origin) assessed as apparent initial rate of oxidation of oxyhemoglobin in presence of cysteine	Homo sapiens	8		protein complex format	Scientific Literature
15.	ALA3223740	B	Activation of soluble guanylate cyclase (unknown origin) assessed as apparent initial rate of oxidation of oxyhemoglobin in presence of cysteine relative to GTN	Homo sapiens	1		protein complex format	Scientific Literature
16.	ALA3223741	B	Activation of soluble guanylate cyclase (unknown origin) assessed as apparent initial rate of oxidation of oxyhemoglobin	Homo sapiens	1		protein complex format	Scientific Literature
17.	ALA3595122	B	Activation of sGC in human hCMEC/D3 cells assessed as production of cGMP per million cells using [3H]-cGMP after 1 hr by liquid scintillation counting	Homo sapiens	9		cell-based format	Scientific Literature
18.	ALA3608014	B	Binding affinity to human recombinant sGC catalytic subunit by surface plasmon resonance analysis	Homo sapiens	17		protein complex format	Scientific Literature
19.	ALA3608023	B	Inhibition of sGC (unknown origin) assessed as inhibition of cGMP production in presence of 1 uM sGC activator cinaciguat	Homo sapiens	1		protein complex format	Scientific Literature
20.	ALA3608024	B	Inhibition of sGC (unknown origin) assessed as inhibition of cGMP production in presence of 20 nM sGC activator cinaciguat	Homo sapiens	1		protein complex format	Scientific Literature